Biotech Firm OKYO Pharma Closes US$2.5 Million IPO

Biotech firm OKYO Pharma Limited (Nasdaq: OKYO) closed on Thursday its initial public offering on the Nasdaq Capital Market. The firm was able to raise approximately US$2.5 million in its debut on the big board.

The offering consisted of 625,000 American depository shares at US$4.00 per share. The company’s shares are trading under the symbol “OKYO”.

Proceeds of the offering are intended for advancing the firm’s drug candidate OK-101 to filing an investigative new drug application, funding the drug’s phase 2 clinical trial, and for working capital and other general corporate purposes.

ThinkEquity acted as the sole bookrunner for the said offering.

The London-based life sciences company is focused on treating patients suffering from inflammatory eye diseases and ocular pain. It is presently developing its lead preclinical product candidate OK-101 to treat dry-eye disease.

OKYO Pharma last traded at US$3.00 on the Nasdaq.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver’s Finally Breaking the System | Keith Neumeyer – First Majestic

The Best News for Gold Was the Drop! – Peter Grandich

McEwen Copper: The Los Azules Feasibility Study

Recommended

Steadright To Conduct Multi-Phased Exploration At Historic Goundafa Polymetallic Mine

Goliath Resources Drills 10.72 g/t Gold Over 7.83 Metres At Surebet

Related News

SPAC Blockchain Moon Acquisition Prices US$100 Million IPO

Special purpose acquisition company Blockchain Moon Acquisition Corp. (Nasdaq: BMAQU) started trading publicly on the...

Tuesday, October 19, 2021, 02:44:00 PM

Robinhood Creating Platform to Allow Amateur Investors to Buy IPOs, Including its Own

While still brushing off daytrader anguish and congressional scrutiny after its decision to pause trading...

Saturday, March 27, 2021, 11:21:00 AM

Nasdaq Stops Chinese Firms’ IPOs While Probe On Stock Rallies Ensues

The Nasdaq has halted the preparations for at least four small Chinese companies’ initial public...

Monday, October 24, 2022, 01:33:00 PM

Apparel Brand Allbirds Prices US$303 Million IPO

Footwear and apparel brand Allbirds, Inc. (Nasdaq: BIRD) started trading on the Nasdaq Global Select...

Wednesday, November 3, 2021, 02:17:00 PM

Railroad SPAC Integrated Rail and Resources Acquisition Prices US$200 Million IPO

Special purpose acquisition company Integrated Rail and Resources Acquisition Corp. (NYSE: IRRXU) went public today...

Friday, November 12, 2021, 02:10:00 PM